-Glycosides are more resistant to enzymatic and chemical hydrolysis and exhibit higher metabolic stability than common -glycosides, demonstrating their widespread application in biological research and drug development. In particular, β--glycosides are used as antirheumatic, anticancer, and antidiabetic drugs in clinical practice. However, the stereoselective synthesis of β--glycosides is still highly challenging. Herein, we report an effective β--glycosylation using 3--trichloroacetimidoyl glycal and thiols under mild conditions. The C3-imidate is designed to guide Pd to form a complex with glucal from the upper face, followed by Pd-S (thiols) coordination to realize β-stereoselectivity. This method demonstrates excellent compatibility with a broad scope of various thiol acceptors and glycal donors with yields up to 87% and a β/α ratio of up to 20:1. The present β--glycosylation strategy is used for late-stage functionalization of drugs/natural products such as estrone, zingerone, and thymol. Overall, this novel and simple operation approach provides a general and practical strategy for the construction of β-thioglycosides, which holds high potential in drug discovery and development.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.joc.4c00698 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!